Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -85.06%2.12B | -32.75%29.78B | 6.55%14.2B | 47.33%44.29B | -6.47%13.33B | -9.69%30.06B | -34.44%14.25B | -31.09%33.28B | 3.20%21.74B | -6.14%48.3B |
| Operating income | -85.06%2.12B | -32.75%29.78B | 6.55%14.2B | 47.33%44.29B | -6.47%13.33B | -9.69%30.06B | -34.44%14.25B | -31.09%33.28B | 3.20%21.74B | -6.14%48.3B |
| Cost of sales | 86.21%-1.56B | 31.03%-29.45B | 15.77%-11.29B | -18.02%-42.7B | 4.59%-13.4B | -22.00%-36.18B | 28.19%-14.05B | 31.02%-29.66B | -9.14%-19.56B | -10.27%-42.99B |
| Operating expenses | 86.21%-1.56B | 31.03%-29.45B | 15.77%-11.29B | -18.02%-42.7B | 4.59%-13.4B | -22.00%-36.18B | 28.19%-14.05B | 31.02%-29.66B | -9.14%-19.56B | -10.27%-42.99B |
| Gross profit | -80.61%564.56M | -78.94%334.37M | 4,013.43%2.91B | 125.94%1.59B | -136.64%-74.42M | -268.66%-6.12B | -90.66%203.11M | -31.70%3.63B | -30.73%2.18B | -57.42%5.31B |
| Selling expenses | 36.06%-74.75M | 46.67%-307.78M | 66.85%-116.9M | 40.60%-577.15M | 51.89%-352.61M | 24.66%-971.65M | -14.42%-732.91M | -2.44%-1.29B | -30.06%-640.54M | -5.00%-1.26B |
| Administrative expenses | -20.67%-294.42M | 9.43%-606.88M | 32.32%-244M | 33.63%-670.05M | 52.03%-360.49M | 15.75%-1.01B | -18.97%-751.48M | 25.27%-1.2B | 8.48%-631.68M | -8.40%-1.6B |
| Revaluation surplus | ---- | -650.92%-532.5M | -163.29%-38.31M | 113.08%96.66M | 104.23%60.53M | -2,191.36%-739.01M | -3,687.06%-1.43B | 82.50%-32.25M | 61.27%-37.76M | -471.02%-184.33M |
| -Changes in the fair value of investment property | ---- | -650.92%-532.5M | -163.29%-38.31M | 113.08%96.66M | 104.23%60.53M | -2,191.36%-739.01M | -3,687.06%-1.43B | 82.50%-32.25M | 61.27%-37.76M | -471.02%-184.33M |
| Impairment and provision | -212.36%-363.6M | -44.83%-3.81B | ---116.41M | -233.61%-2.63B | ---- | -17,237.43%-788.32M | ---- | --4.6M | ---- | ---- |
| -Other impairment is provision | -212.36%-363.6M | -44.83%-3.81B | ---116.41M | -233.61%-2.63B | ---- | -17,237.43%-788.32M | ---- | --4.6M | ---- | ---- |
| Special items of operating profit | 171.58%26.16M | -186.87%-2.35B | -195.76%-36.54M | 16.90%-820.29M | 104.65%38.16M | -185.27%-987.1M | -296.55%-820.93M | 71.24%1.16B | -2.70%417.68M | 126.74%676.03M |
| Operating profit | -106.02%-142.06M | -141.42%-7.27B | 442.63%2.36B | 71.61%-3.01B | 80.50%-688.83M | -567.60%-10.62B | -375.27%-3.53B | -22.81%2.27B | -43.96%1.28B | -71.01%2.94B |
| Financing income | -45.65%13.56M | -40.13%45.79M | -50.60%24.95M | -72.53%76.48M | -70.64%50.51M | -62.20%278.39M | -54.07%172.03M | -59.27%736.49M | 13.94%374.58M | 623.56%1.81B |
| Financing cost | 16.76%-1.26B | 2.83%-2.68B | -5.34%-1.51B | -32.17%-2.76B | -16.27%-1.43B | -228.39%-2.09B | -1,152.13%-1.23B | -38.48%-636.27M | 64.23%-98.49M | 27.01%-459.48M |
| Special items of earning before tax | -106.79%-6.18M | -76.58%146.56M | 398.44%90.99M | 21.70%625.82M | -95.23%18.25M | 402.96%514.22M | 449.73%382.32M | -83.28%102.24M | -49.53%69.55M | -31.73%611.46M |
| Earning before tax | -244.17%-1.39B | -92.52%-9.77B | 147.01%965.57M | 57.42%-5.07B | 51.22%-2.05B | -581.76%-11.91B | -358.54%-4.21B | -49.55%2.47B | -34.34%1.63B | -54.02%4.9B |
| Tax | 64.76%-312.1M | -0.98%-1.79B | -114.49%-885.59M | -236.21%-1.77B | -14.84%-412.89M | 29.23%-527.83M | 38.89%-359.54M | 46.98%-745.87M | 29.55%-588.35M | 70.49%-1.41B |
| After-tax profit from continuing operations | -2,230.78%-1.7B | -68.80%-11.56B | 103.24%79.98M | 44.96%-6.85B | 46.03%-2.47B | -820.43%-12.44B | -539.30%-4.57B | -50.59%1.73B | -36.77%1.04B | -40.71%3.49B |
| Earning after tax | -2,230.78%-1.7B | -68.80%-11.56B | 103.24%79.98M | 44.96%-6.85B | 46.03%-2.47B | -820.43%-12.44B | -539.30%-4.57B | -50.59%1.73B | -36.77%1.04B | -40.71%3.49B |
| Minority profit | -93.78%125.02M | 147.90%444.27M | 523.85%2.01B | 23.03%-927.58M | -235.90%-474.4M | -379.17%-1.21B | -139.68%-141.23M | -59.52%431.68M | -51.71%355.89M | -60.93%1.07B |
| Profit attributable to shareholders | 5.26%-1.83B | -102.75%-12B | 3.10%-1.93B | 47.31%-5.92B | 55.02%-1.99B | -967.52%-11.23B | -747.07%-4.43B | -46.66%1.3B | -24.65%684.51M | -23.02%2.43B |
| Basic earnings per share | 5.22%-1.09 | -102.56%-7.13 | 2.54%-1.15 | 47.23%-3.52 | 55.13%-1.18 | -966.23%-6.67 | -741.46%-2.63 | -46.15%0.77 | -22.64%0.41 | -23.53%1.43 |
| Diluted earnings per share | 5.22%-1.09 | -102.56%-7.13 | 2.54%-1.15 | 47.23%-3.52 | 55.13%-1.18 | -966.23%-6.67 | -741.46%-2.63 | -45.77%0.77 | -22.64%0.41 | -23.24%1.42 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unaudited opinion | -- | Unqualified Opinion |
| Auditor | -- | Zhongrui Hexin Certified Public Accountants Co., Ltd. | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | PwC Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.